MacroGenics (MGNX) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free MGNX Stock Alerts $16.37 +0.70 (+4.47%) (As of 05/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMacroGenics (MGNX) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - May 4 at 9:21 AMMacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - May 4 at 2:40 AMMacroGenics Announces Date of First Quarter 2024 Financial Results Conference Callfinance.yahoo.com - May 3 at 10:37 AMBiotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050theglobeandmail.com - May 1 at 1:07 PMMacroGenics (NASDAQ:MGNX) Research Coverage Started at B. Rileyamericanbankingnews.com - April 29 at 4:30 AMMacroGenics, Inc. (NASDAQ:MGNX) Short Interest Updatemarketbeat.com - April 28 at 7:31 AMMacroGenics (NASDAQ:MGNX) Shares Gap Up to $14.37americanbankingnews.com - April 28 at 2:40 AMB. Riley Begins Coverage on MacroGenics (NASDAQ:MGNX)marketbeat.com - April 26 at 8:24 AMBuy Rating Affirmed for MacroGenics on Strong Oncology Pipeline and Positive Phase II Trial Resultsmarkets.businessinsider.com - April 26 at 6:35 AMMacroGenics (NASDAQ:MGNX) Trading Down 9%marketbeat.com - April 25 at 7:46 PMMacroGenics, Inc. (NASDAQ:MGNX) Shares Sold by Federated Hermes Inc.marketbeat.com - April 25 at 5:34 AMMacroGenics, Inc. (MGNX)finance.yahoo.com - April 21 at 8:23 AMWe're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wiselyfinance.yahoo.com - April 19 at 10:59 AMMacroGenics, Inc. (MGNX) Interactive Stock Chart - Yahoo Financeca.finance.yahoo.com - April 18 at 8:22 AMBuy Rating Affirmed for MacroGenics with Promising Vobra Duo Data and Anticipated 2024 Clarificationsmarkets.businessinsider.com - April 10 at 7:21 PMValidea Detailed Fundamental Analysis - MGNXnasdaq.com - April 10 at 12:40 AMMacroGenics (NASDAQ:MGNX) Upgraded by TD Cowen to "Buy"marketbeat.com - April 9 at 8:30 AMJeffrey Stuart Peters Sells 51,395 Shares of MacroGenics, Inc. (NASDAQ:MGNX) Stockinsidertrades.com - April 9 at 5:04 AMMacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - April 9 at 2:45 AMMacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidateuk.investing.com - April 6 at 12:52 PMMacroGenics (NASDAQ:MGNX) Shares Up 4.7%marketbeat.com - April 5 at 12:51 PMMacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024seekingalpha.com - April 5 at 2:31 AMMacroGenics (NASDAQ:MGNX) Shares Gap Up to $13.67marketbeat.com - April 4 at 1:20 PMBuy Rating Affirmed for MacroGenics on Strong Safety Profile and Anticipated Efficacy Datamarkets.businessinsider.com - April 4 at 1:02 PMThe Latest Analyst Ratings For Macrogenicsmarkets.businessinsider.com - April 4 at 1:02 PMMacroGenics (NASDAQ:MGNX) Stock Rating Reaffirmed by JMP Securitiesmarketbeat.com - April 4 at 9:15 AMSimulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Sessionmarkets.businessinsider.com - April 4 at 8:02 AMMacroGenics gains after mid-stage data for antibody drug conjugatemsn.com - April 4 at 8:02 AMPositive Outlook for MacroGenics: Buy Rating Affirmed Amid Vobra-duo Developmentsmarkets.businessinsider.com - April 4 at 2:05 AMMacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosuresglobenewswire.com - April 3 at 4:30 PMMacroGenics (NASDAQ:MGNX) Stock Price Down 3.6%marketbeat.com - March 28 at 4:33 PMMGNX Apr 2024 10.000 putfinance.yahoo.com - March 16 at 3:33 AMMGNX Dec 2024 17.500 putfinance.yahoo.com - March 16 at 3:33 AMMGNX Mar 2024 22.500 putca.finance.yahoo.com - March 15 at 2:30 AMMacroGenics, Inc. (NASDAQ:MGNX) Short Interest Down 21.3% in Februarymarketbeat.com - March 14 at 3:35 PMThe Potential of MacroGenics’ (NASDAQ:MGNX) Pipeline is Driving the Stockmsn.com - March 14 at 9:30 AMMacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 14 at 9:30 AMMacroGenics (NASDAQ:MGNX) Stock Price Down 4.9%marketbeat.com - March 13 at 2:16 PMMacroGenics price target raised by $6 at JMP Securities, here's whyrealmoney.thestreet.com - March 11 at 1:22 PM3 Best Stocks to Buy Now, 3/11/2024, According to Top Analystsmsn.com - March 11 at 8:21 AMMacroGenics price target raised by $12 at Citi, here's whyrealmoney.thestreet.com - March 11 at 8:21 AMMaintaining Market Outperform for MacroGenics with Increased Confidence in ADC Leadership and Clinical Prospectsmarkets.businessinsider.com - March 11 at 8:21 AMBuy Rating Affirmed for MacroGenics on Promising Pipeline and Strong Financialsmarkets.businessinsider.com - March 11 at 8:21 AMMacroGenics (NASDAQ: MGNX)fool.com - March 10 at 7:52 PMGSA Capital Partners LLP Purchases 96,760 Shares of MacroGenics, Inc. (NASDAQ:MGNX)marketbeat.com - March 10 at 7:49 AMMacroGenics (NASDAQ:MGNX) Issues Earnings Resultsmarketbeat.com - March 8 at 11:54 AMMacroGenics (MGNX) Q4 2023 Earnings Call Transcriptfool.com - March 8 at 8:20 AMMGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023msn.com - March 7 at 10:57 PMMacrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ...finance.yahoo.com - March 7 at 10:57 PMMacrogenics: Q4 Earnings Insightsbenzinga.com - March 7 at 5:55 PM Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Is Tesla going out of business? (Ad)Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market. Click here for the full story MGNX Media Mentions By Week MGNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGNX News Sentiment▼0.150.40▲Average Medical News Sentiment MGNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGNX Articles This Week▼42▲MGNX Articles Average Week Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Centessa Pharmaceuticals News ABIVAX Société Anonyme News Tyra Biosciences News Cassava Sciences News Liquidia News Homology Medicines News ALX Oncology News OPKO Health News ARS Pharmaceuticals News Immunome News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGNX) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.